Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of other drugs on Inaxaplin
6 evidence topics · 2 sources
CYP3A4 and P-glycoprotein substrate
Rifampin and itraconazole drug interaction study in healthy adults
Strong CYP3A and P-gp inducer: rifampin
Strong CYP3A4 and P-gp inhibitor: itraconazole; moderate CYP3A4 inhibitor: cyclosporine
Restricted medications and foods in the phase 2a study
| Restriction | Start | Stop |
|---|---|---|
| CYP3A4 inhibitors or inducers | “None allowed within 14 days before the first dose of the study drug” | “Completion of Safety Follow-up Visit assessments” |
| Grapefruit and related fruits | “7 days before first dose of study drug” | “Until last PK sample is taken” |